Amy Fu

Amy Fu is an active researcher specializing in nanomedicine and biophotonics with significant contributions to developing nanotechnology-based solutions for disease diagnosis and treatment. Her work focuses on creating innovative nanoparticle systems for targeted drug delivery, bioimaging applications, and point-of-care diagnostics, particularly for neurological conditions and cancer. With an ORCID profile (0000-0001-8871-358X) showing 20 research outputs between 2012-2023, she maintains an active research trajectory in the biomedical nanotechnology field.

Research Focus: Her primary research interests include biophotonics for early-stage disease diagnosis, upconversion nanocrystals for targeted drug delivery systems, super-resolution bioimaging to study nanoparticle-cell interactions, and advanced nano-bio hybrids for cancer and neurodegenerative disease therapy. She has developed specialized DNA biosensors and transduction mechanisms for genosensing applications. Her fingerprint analysis reveals strong expertise in nanoparticle research (100%), DNA chemistry (87%), and upconversion nanomaterials (33%).

Publication Trends: Analysis of her recent publications (2019-2023) shows a consistent focus on overcoming the blood-brain barrier using novel nanoparticle systems, with particular emphasis on upconversion nanomaterials and poly(amidoamine) dendrimers. Her work bridges nanotechnology, neuroscience, and cancer therapeutics, demonstrating innovation in nanocarrier design, cellular uptake mechanisms, and therapeutic applications for glioma and neurodegenerative conditions. The publications show strong interdisciplinary collaboration across materials science, pharmacology, and biomedical engineering.

Research Projects:

• OOA_Brain Foundation: In vitro testing of thrombotic nanodisks for vascular targeting of AVMs (2019) - Served as Co-Investigator alongside Principal Investigator Zhao, Z. and collaborators Stoodley, M., Shi, B., and McRobb, L.

Collaboration Network: Her research shows significant external collaboration across multiple territories, with strong connections in nanoparticle research, DNA chemistry, and surface science. She maintains active research partnerships with colleagues including Shi, B., Stoodley, M., Wang, G., Lu, Y., and Chung, R. in the development of nanomedicine applications.